Theranostics Market worth $6.18 billion by 2030, growing at a CAGR of 14.89% - Exclusive Report by 360iResearch

The "Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Theranostics Market to grow from USD 2.33 billion in 2023 to USD 6.18 billion by 2030, at a CAGR of 14.89%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/theranostics?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Theranostics represents an innovative field in medical science that combines diagnostics with targeted therapy based on diagnostic test results. This approach enables personalized treatment, allowing for more efficient and effective healthcare delivery by tailoring treatment to the individual's specific disease characteristics. The primary applications of theranostics include oncology, cardiovascular diseases, neurological disorders, and infectious diseases, among others. The end-users of theranostics are largely hospitals and clinics, diagnostic laboratories, and research institutions, where the integration of therapeutic and diagnostic processes can significantly enhance patient care. The increasing prevalence of target diseases worldwide is expanding the need for theranostics. The growing inclination towards personalized medicines and rising advancements in molecular biology are expanding the usage of theranostics. Additionally, the growth of healthcare infrastructure and increasing investments in R&D activities globally serve as key drivers for the growth of the theranostics market. High costs associated with R&D and issues related to data privacy and the ethical considerations of personalized medicine pose significant challenges to market growth. Growing development of novel biomarkers, non-invasive imaging techniques, and precision therapeutics are expected to create opportunities for market growth. The integration of data analytics and machine learning presents a frontier for developing predictive models for patient response, optimizing treatment regimens, and monitoring disease progression.

The Americas represents a highly developing landscape for theranostics market development, characterized by high healthcare expenditure, robust patent registrations, and significant investments in personalized medicine. Growing awareness of personalized healthcare benefits with rising public and private sector investments for research and application in theranostics are expected to create a platform for the market in the Americas. In the European Union (EU), regulatory support, along with strong healthcare systems, promotes the growth of the theranostics market. Countries including Germany, France, and the UK are at the forefront, with research centered on oncology and neurodegenerative diseases. The Middle East shows emerging interest, propelled by investments in healthcare infrastructure and partnerships with Western biotech firms. Africa displays potential particularly in regions with developing healthcare systems, focusing on accessible diagnostic services. Asia Pacific is rapidly emerging as a significant region in the theranostics field, backed by government initiatives aimed at boosting innovation in personalized medicine. Japan's aging population drives need for advanced theranostic solutions, particularly in oncology and cardiovascular diseases. India, with its growing healthcare sector and focus on affordable care, is witnessing increased investment in localized theranostic research and collaborations.

Market Segmentation & Coverage:

This research report categorizes the Theranostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Product, Services, and Software. The Product is further studied across Diagnostic Imaging, In Vitro Diagnostics/Biomarker Screening, and Radiopharmaceuticals. The Diagnostic Imaging is further studied across Functional Imaging, Molecular Imaging, and Nuclear Imaging. The In Vitro Diagnostics/Biomarker Screening is further studied across Fluorescence In Situ Hybridization, Next-generation Sequencing, and Polymerase Chain Reaction. The Radiopharmaceuticals is further studied across Fluorine-18, Gallium-68, lodine-131, Lutetium-177, Radium-223, Samarium-153, Strontium-89, Technetium-99, and Yttrium-90. The Software is further studied across Imaging Analytics and Predictive Modeling. The Services is projected to witness significant market share during forecast period.

Based on Application, market is studied across Bone Metastatis, Cardiovascular Diseases, Lymphoma, Neuroendocrine Tumors, and Prostate Cancer. The Cardiovascular Diseases is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Cancer Care Centers, Hospitals, Research & Academic Centers, and Theranostics Centers. The Theranostics Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 36.53% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/theranostics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Theranostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Theranostics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Theranostics Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Ariceum Therapeutics GmbH, Astellas Pharma Inc., BAMF Health, Bayer AG, bioMérieux SA, Biosynth Ltd., Cardinal Health, Inc., Cerebral Therapeutics, Inc., Clarity Pharmaceuticals, Curasight A/S, Curium Inc., Evergreen Theragnostics, Inc., GE HealthCare Technologies, Inc., Hermes Medical Solutions AB, Icon Group, Indi Molecular, Inc., Integrated Clinical Oncology Network Pty Ltd., Invicro, LLC, Ipsen Pharma, Radiopharm Theranostics Limited, Ratio Therapeutics, Siemens Healthineers AG, SOFIE Co., Telix Pharmaceuticals Limited, and United Theranostics.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Theranostics Market, by Product
7. Theranostics Market, by Application
8. Theranostics Market, by End-User
9. Americas Theranostics Market
10. Asia-Pacific Theranostics Market
11. Europe, Middle East & Africa Theranostics Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Theranostics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Theranostics Market?
3. What is the competitive strategic window for opportunities in the Theranostics Market?
4. What are the technology trends and regulatory frameworks in the Theranostics Market?
5. What is the market share of the leading vendors in the Theranostics Market?
6. What modes and strategic moves are considered suitable for entering the Theranostics Market?

Read More @ https://www.360iresearch.com/library/intelligence/theranostics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.